OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 141 filers reported holding OCULAR THERAPEUTIX INC in Q3 2021. The put-call ratio across all filers is 0.59 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $353,000 | -4.1% | 71,224 | +93.3% | 0.02% | -41.4% |
| Q3 2021 | $368,000 | +59.3% | 36,840 | +126.2% | 0.03% | +52.6% |
| Q2 2021 | $231,000 | -55.0% | 16,286 | -47.9% | 0.02% | -59.6% |
| Q1 2021 | $513,000 | +105.2% | 31,263 | -4.7% | 0.05% | +193.8% |
| Q3 2020 | $250,000 | +145.1% | 32,791 | +167.6% | 0.02% | +128.6% |
| Q2 2020 | $102,000 | -26.6% | 12,252 | -39.3% | 0.01% | -30.0% |
| Q3 2018 | $139,000 | -23.2% | 20,190 | -6.8% | 0.01% | -65.5% |
| Q4 2016 | $181,000 | +40.3% | 21,663 | +57.8% | 0.03% | +163.6% |
| Q4 2015 | $129,000 | -14.6% | 13,731 | +27.5% | 0.01% | -15.4% |
| Q3 2015 | $151,000 | -54.1% | 10,772 | -31.4% | 0.01% | -64.9% |
| Q2 2015 | $329,000 | -16.1% | 15,700 | +68.0% | 0.04% | -7.5% |
| Q1 2015 | $392,000 | – | 9,348 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SUMMER ROAD LLC | 6,122,089 | $32,263 | 100.00% |
| Opaleye Management Inc. | 6,105,900 | $32,178,093 | 9.64% |
| DELTEC ASSET MANAGEMENT LLC | 1,913,612 | $10,084,735 | 2.49% |
| Knoll Capital Management, LLC | 200,000 | $1,504,000 | 2.32% |
| Endurant Capital Management LP | 512,744 | $2,702,161 | 1.39% |
| Knoll Capital Management, LLC | 95,800 | $504,866 | 0.78% |
| Covestor Ltd | 60,008 | $316 | 0.28% |
| Ikarian Capital, LLC | 200,000 | $1,054,000 | 0.24% |
| EAM Investors, LLC | 224,211 | $1,181,592 | 0.23% |
| Nebula Research & Development LLC | 22,474 | $118,438 | 0.21% |